13F Data
13F filer · CIK 1892134

Frazier Life Sciences Management, L.P.

PALO ALTO, CA · filing since Q1 2022 · last filing Aug 14, 2026
Reported value
$4.6B
+$705.6M vs prior
Positions
41
New / sold out
6 / 3
Added / reduced
8 / 2
Turnover
8.0%
buys $338.3M · sells $349.6M
Top-10 weight
73.6%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewPARABILIS MEDICINES INC+1,920,805–+$52.6M
NewACHIEVE LIFE SCIENCE INC+7,614,836–+$49.7M
AddedNEWAMSTERDAM PHARMA COMPANY+1,145,128+6.8%+$38.8M
AddedALLOGENE THERAPEUTICS INC+18,650,000+491.2%+$38.8M
NewDESIGN THERAPEUTICS INC+1,809,854–+$26.2M
NewSHATTUCK LABS INC+3,750,000–+$26.0M
AddedASCENDIS PHARMA A/S+91,822+68.9%+$24.5M
NewKAILERA THERAPEUTICS INC+1,100,000–+$24.2M
NewRELAY THERAPEUTICS INC+1,015,693–+$19.0M
AddedAURA BIOSCIENCES INC+2,000,000+39.2%+$14.2M
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedBRIDGEBIO PHARMA INC-1,900,000-55.1%$-141.5M
Sold outKALVISTA PHARMACEUTICALS INC-4,961,108-100.0%$-99.9M
Sold outREVOLUTION MEDICINES INC-675,686-100.0%$-65.7M
Sold outAGIOS PHARMACEUTICALS INC-1,256,080-100.0%$-42.5M
ReducedTREVI THERAPEUTICS INC-100-0.0%$-1.9K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q1 2022: $1.2BQ2 2022: $1.1BQ3 2022: $1.3BQ4 2022: $1.6BQ1 2023: $1.4BQ2 2023: $1.7BQ3 2023: $1.5BQ4 2023: $1.9BQ1 2024: $2.4BQ2 2024: $2.1BQ3 2024: $2.5BQ4 2024: $2.4BQ1 2025: $2.2BQ2 2025: $2.5BQ3 2025: $3.3BQ4 2025: $3.7BQ1 2026: $3.9BQ2 2026: $4.6B
Q1 2022Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1MIRUM PHARMACEUTICALS INCCOM7,679,684$899.1M19.58%
2NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES18,088,902$613.0M13.35%
3ERASCA INCCOM24,975,188$457.5M9.96%
4MBX BIOSCIENCES INCCOM6,652,013$367.2M8.00%
5ARCUTIS BIOTHERAPEUTICS INCCOM9,874,511$258.9M5.64%
6TREVI THERAPEUTICS INCCOM9,939,447$185.4M4.04%
7KRYSTAL BIOTECH INCCOM481,307$178.9M3.90%
8MAZE THERAPEUTICS INCCOM5,032,915$150.2M3.27%
9PHATHOM PHARMACEUTICALS INCCOM12,466,489$135.3M2.95%
10PALVELLA THERAPEUTICS INC NECOM882,400$134.8M2.94%
31 more rows. Subscribe for $29/month to see every row, download the data and use the API.